Plain-English translation of NCT05370014 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a 14-week support program called iCINGS FAM can help African American adults who were hospitalized with COVID-19 and have chronic conditions like diabetes or heart disease manage their health better. The program pairs each patient with their family caregiver and provides guidance from a registered nurse and community health worker through telehealth (video or phone calls). The study wants to see if this kind of personalized, family-based support can reduce stress and improve how well people manage their ongoing health conditions.
African American communities have been hit particularly hard by COVID-19, especially people with existing chronic diseases, and often face extra barriers to healthcare and support. This study exists to test whether including both the patient and their caregiver in a structured support program can help them both stay healthier and feel less stressed after COVID-19.
You likely qualify if…
You likely don't qualify if…
If you are chosen for the treatment group, you and your caregiver will attend two planning sessions in the first 2 weeks, then participate in 8 guided sessions with a nurse or community health worker over the next 12 weeks (weekly at first, then every other week). All sessions happen by phone or video. You'll also complete brief assessments at the start, after 4 months, and after 7 months. If you're in the comparison group, you'll receive 3 short phone calls (about 7–10 minutes each) over a few months with general health information from public health agencies.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States